State of Wisconsin Investment Board’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,040
Closed -$130K 2406
2023
Q4
$130K Sell
3,040
-8,560
-74% -$272K ﹤0.01% 2252
2023
Q3
$403K Sell
11,600
-1,670
-13% -$72.8K ﹤0.01% 1918
2023
Q2
$617K Buy
13,270
+1,320
+11% +$65.7K ﹤0.01% 1726
2023
Q1
$552K Buy
11,950
+860
+8% +$54.6K ﹤0.01% 1832
2022
Q4
$896K Sell
11,090
-1,586
-13% -$110K ﹤0.01% 1551
2022
Q3
$704K Sell
12,676
-3,321
-21% -$197K ﹤0.01% 1764
2022
Q2
$833K Buy
15,997
+4,474
+39% +$250K ﹤0.01% 1764
2022
Q1
$947K Buy
11,523
+5,910
+105% +$562K ﹤0.01% 1653
2021
Q4
$835K Hold
5,613
﹤0.01% 1512
2021
Q3
$1.06M Hold
5,613
﹤0.01% 1433
2021
Q2
$1.04M Buy
5,613
+1,970
+54% +$386K ﹤0.01% 1437
2021
Q1
$829K Hold
3,643
﹤0.01% 1418
2020
Q4
$791K Buy
3,643
+930
+34% +$154K ﹤0.01% 1392
2020
Q3
$273K Buy
2,713
+1,033
+61% +$97.6K ﹤0.01% 1857
2020
Q2
$130K Hold
1,680
﹤0.01% 1620
2020
Q1
$171K Buy
1,680
+50
+3% +$5.25K ﹤0.01% 1577
2019
Q4
$179K Hold
1,630
﹤0.01% 1588
2019
Q3
$148K Buy
+1,630
New +$165K ﹤0.01% 1520

Other funds holding STRO

State of Wisconsin Investment Board's STRO Position: Q1 2024 in Review

State of Wisconsin Investment Board sold out of Sutro Biopharma (STRO) in Q1 2024, closing a stake of 3,040 shares — an estimated $130K sold.

State of Wisconsin Investment Board first reported a position in STRO in Q3 2019 and held it in 18 quarters. The position peaked at $1.06M in Q3 2021. 117 funds tracked by Wall St. Rank hold STRO as of Q1 2024.

  • State of Wisconsin Investment Board reported no remaining Sutro Biopharma position as of Q1 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 3,040 Sutro Biopharma shares in Q1 2024, an estimated $130K.
  • State of Wisconsin Investment Board first reported a position in Sutro Biopharma in Q3 2019 and held it in 18 quarters.
  • State of Wisconsin Investment Board's Sutro Biopharma position peaked at $1.06M in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.